A woman being helped by her nurse for an x-ray

Discover What DNA Reveals About Your Breast Health

Update: WholeMe will be closing registration for new participants on December 16th.

The next phase of WholeMe genomic testing is here to help women feel informed about their breast cancer risk. AdventHealth will be partnering with Helix, a population genomics company, and Sema4, a patient-centered health intelligence company, to deliver more comprehensive breast cancer DNA test results.

This new study will enroll participants as they are scheduling their annual mammography appointments (at a participating site) and provide a breast cancer risk assessment to all participants.

If you choose to participate, your assessment will be given before your mammogram appointment.

  • Those at high risk will receive a clinical referral to an AdventHealth high-risk clinic and no further study activities are required.
  • Those at low/average risk would have no further study activities.
  • Those at moderate risk will be asked to provide a saliva sample for genetic testing during their mammogram appointment.
A woman thinking while on her laptop

Partnering for More Health Insights

We're excited to inform you that the AdventHealth WholeMe research study is evolving! In this new chapter, AdventHealth will be partnering with Sema4, a patient-centered health intelligence company, to deliver even more comprehensive DNA test results.

As part of your WholeMe participation and consent, interpretations for breast and ovarian cancers will be completed. A full list of genes can be found below.

You'll have access to a care navigator who will assist you with the next steps. If you have a positive result in one of the genes being tested, you may be asked to complete a series of follow-up appointments, including:

  1. A confirmatory genetic test with Sema4: a new saliva kit will be sent directly to your home with instructions for providing your sample and mailing it back.
  2. A genetic counseling session with Sema4: this can be scheduled directly with Sema4 through their patient portal and is done as a virtual visit.
  3. An appointment with one of AdventHealth's medical geneticists: a care navigator will assist with scheduling this follow-up appointment.

We recommend creating an AdventHealth account so you can access your results as soon as they are available. You can register for an account here.

If you have any questions, please reach out to the WholeMe Research team via email at [email protected].

Whole Me Breast Cancer Genes

This study will look at the following hereditary breast cancer genes that may indicate increased risk:
  • ATM
  • BARD1
  • BRCA1
  • BRCA2
  • CDH1
  • CHEK2
  • NF1
  • PALB2
  • PTEN
  • STK11
  • TP5

Upcoming Study Sites

The WholeMe study will be enrolling potential participants who schedule at the following locations:

Dates for Enrollment


May 1 – June 29, 2022

AdventHealth Imaging Center Princeton, AdventHealth Winter Park

July 1 – August 31, 2022

AdventHealth Imaging Center Lake Mary, AdventHealth Apopka

September 1 – October 31, 2022

AdventHealth Imaging Center Winter Garden, AdventHealth Celebration

November 1 – December 31, 2022

AdventHealth Imaging Center Princeton, AdventHealth Kissimmee

If you’re interested in enrolling in WholeMe, click below to complete the form and our study team will be in touch.

WholeMe: Genomics 101

1 items. To interact with these items, press Control-Option-Shift-Right Arrow.
  • With Genomics, your doctor can truly personalize your health care as well as help prevent, diagnose and treat serious health risks.

A woman reviews her test results with her doctor.

Breast Cancer Resources

Whether you've received a new diagnosis or are looking for more support, we have a variety of resources available to you. Learn more about some of the services we offer through our AdventHealth Cancer Institute.

Genetic Counseling

Patient Education

Support Groups and Programs

Is Knowledge Power?

What if doctors could uncover your risk for disease and help you prevent it? Or determine whether a therapy or dose of medicine will be effective for your specific health needs? What if your health care plan was based on a sample size of 1 – just you?

With genomic profiles, physicians and researchers can determine with unprecedented accuracy if someone is at risk for cancer, heart disease and other conditions. From disease prevention to diagnosis to treatment, genomics is the future of medicine and will be an essential component of all health care.

In 2019, we began laying the foundation for our comprehensive program — AdventHealth Genomics and Personalized Health — which will ultimately provide comprehensive genomics testing, analysis, interpretation and genetic counseling services.

When it comes to treating the whole person, our genomics program will deliver on the renewed focus we promised during the launch of our new brand, AdventHealth. We believe personalized medicine that focuses on the whole person is superior health care and nothing is more personal than your DNA.

At AdventHealth, we believe knowledge is power.

Frequently Asked Questions

19 items. To interact with these items, press Control-Option-Shift-Right Arrow